You are here:
Publication details
Virová hepatitida B
| Title in English | Viral hepatitis B |
|---|---|
| Authors | |
| Year of publication | 2026 |
| Type | Chapter in a book |
| MU Faculty or unit | |
| Citation | |
| Attached files | |
| Description | The hepatitis B virus is spread primarily through sexual contact. It is estimated that more than two billion people will become infected with the hepatitis B virus during their lifetime, and currently around 240 million people are chronically infected. If signs of HBV infection persist for longer than six months, this is referred to as chronic hepatitis B. Chronic hepatitis B can be treated with tenofovir, entecavir or pegylated interferon-alpha-2a. The available medicines cannot completely eliminate HBV infection; treatment is considered successful if it induces long-term clinical (absence of symptoms), biochemical (normalisation of ALT levels), serological (seroconversion HBeAg/anti-HBe in the HBeAg-positive form of the disease) and virological remission (serum HBV DNA below the detection limit by real-time PCR). |